These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23381595)

  • 1. Author's reply: CRP kinetics could be prognostic predictors in urothelial cancer.
    Saito K; Kihara K
    Nat Rev Urol; 2013 Mar; 10(3):182. PubMed ID: 23381595
    [No Abstract]   [Full Text] [Related]  

  • 2. C-reactive protein in bladder cancer: where do we stand?
    Gakis G; Stenzl A
    Nat Rev Urol; 2013 Mar; 10(3):182. PubMed ID: 23381597
    [No Abstract]   [Full Text] [Related]  

  • 3. C-reactive protein as a biomarker for urological cancers.
    Saito K; Kihara K
    Nat Rev Urol; 2011 Oct; 8(12):659-66. PubMed ID: 22025173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic value of PD-1/PD-L1 expression in upper tract urothelial carcinoma].
    Campedel L; Seisen T; Cussenot O; Comperat E; Varinot J; Rouprêt M; Cancel-Tassin G
    Prog Urol; 2018 Dec; 28(16):900-905. PubMed ID: 30219646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MicroRNAs as potential noninvasive markers in the diagnosis of urological malignancies].
    Gilyazova IR; Klimentova EA; Pavlov VN; Khusnutdinova EK
    Urologiia; 2016 Apr; (2):96-102. PubMed ID: 28247670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein in urologic cancers.
    Huang J; Baum Y; Alemozaffar M; Ogan K; Harris W; Kucuk O; Master VA
    Mol Aspects Med; 2015 Nov; 45():28-36. PubMed ID: 25936279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular markers in the diagnostics and therapy of urothelial cancer].
    Protzel C; Hakenberg OW
    Urologe A; 2010 Nov; 49(11):1415-24. PubMed ID: 20959953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The translational potential of microRNAs as biofluid markers of urological tumours.
    Fendler A; Stephan C; Yousef GM; Kristiansen G; Jung K
    Nat Rev Urol; 2016 Dec; 13(12):734-752. PubMed ID: 27804986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical Analysis of Urothelial Carcinoma Tissues for Proliferation and Differentiation Markers.
    Rose M; Gaisa NT
    Methods Mol Biol; 2018; 1655():43-52. PubMed ID: 28889376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular signatures in urologic tumors.
    Larkin S; Kyprianou N
    Int J Mol Sci; 2013 Sep; 14(9):18421-36. PubMed ID: 24018887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.
    Chiang CY; Pan CC; Chang HY; Lai MD; Tzai TS; Tsai YS; Ling P; Liu HS; Lee BF; Cheng HL; Ho CL; Chen SH; Chow NH
    Clin Cancer Res; 2015 Dec; 21(24):5601-11. PubMed ID: 26286913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteome research in urothelial carcinoma.
    Kageyama S; Isono T; Iwaki H; Hanada E; Tomita K; Yoshida T; Yoshiki T; Kawauchi A
    Int J Urol; 2015 Jul; 22(7):621-8. PubMed ID: 25944546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion.
    Kosaka T; Kikuchi E; Mikami S; Miyajima A; Shirotake S; Ishida M; Okada Y; Oya M
    Clin Cancer Res; 2010 Dec; 16(23):5814-23. PubMed ID: 20947514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100P as a Marker for Urothelial Histogenesis: A Critical Review and Comparison With Novel and Traditional Urothelial Immunohistochemical Markers.
    Suryavanshi M; Sanz-Ortega J; Sirohi D; Divatia MK; Ohe C; Zampini C; Luthringer D; Smith SC; Amin MB
    Adv Anat Pathol; 2017 May; 24(3):151-160. PubMed ID: 28398953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue microarrays: applications in urological cancer research.
    Merseburger AS; Anastasiadis AG; Hennenlotter J; Schilling D; Simon P; Machtens SA; Serth J; Stenzl A; Kuczyk MA
    World J Urol; 2006 Nov; 24(5):579-84. PubMed ID: 16896596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Role of C-Reactive Protein In Urological Cancers: A Meta-Analysis.
    Zhou L; Cai X; Liu Q; Jian ZY; Li H; Wang KJ
    Sci Rep; 2015 Aug; 5():12733. PubMed ID: 26235332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma.
    Tsuzuki S; Kimura S; Fukuokaya W; Yanagisawa T; Hata K; Miki J; Kimura T; Abe H; Egawa S
    Jpn J Clin Oncol; 2021 Jan; 51(1):138-144. PubMed ID: 32728722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implication of the mammalian target of rapamycin pathway in upper tract urothelial carcinoma with negative GATA binding protein 3 expression.
    Yamamoto Y; Fujita K; Munari E; Uemura M; Miyamoto H; Netto GJ
    Int J Urol; 2019 Jun; 26(6):678-679. PubMed ID: 30854704
    [No Abstract]   [Full Text] [Related]  

  • 19. Nuclear, but not cytoplasmic, localization of survivin as a negative prognostic factor for survival in upper urinary tract urothelial carcinoma.
    Kitamura H; Torigoe T; Hirohashi Y; Asanuma H; Inoue R; Nishida S; Tanaka T; Masumori N; Sato N; Tsukamoto T
    Virchows Arch; 2013 Jan; 462(1):101-7. PubMed ID: 23179762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas.
    Thomas CY; Theodorescu D
    World J Urol; 2006 Nov; 24(5):565-78. PubMed ID: 17063322
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.